| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |